Dernière minute
TRErzurum'da 7'nci kattan düşen halı, mağaza çalışanının başına isabet ettiTRBenzine zam pompaya yansıdı: Bazı illerde litre fiyatı 70 TL'ye yaklaştıTRBrandon Davies 34 Yaşında Basketbolu Bıraktığını AçıkladıTRÖSYM'den Okul Birinciliği Bilgileri İçin Önemli DuyuruTRGalatasaray, Can Uzun transferinde vites yükseltti: Pazarlıklarda ilerleme varTRFethiye'deki Orman Yangını Kontrol Altına Alındı, Evlerin Bahçesine Ulaştığı Anlar KameradaTRRojin Kabaiş'in Telefonu Çin'de de Açılamadı: Tüm Veriler Silinebilir UyarısıTRLavrov, ABD'nin Ukrayna'ya silah sevkiyatını 'kabul edilemez' buldu; AB'den yeni yaptırım paketiTRLGS Türkiye Birincisi Meryem Sakman Tercihini YaptıTRAB, Rusya'ya Yönelik 21. Yaptırım Paketini OnayladıTRErzurum'da 7'nci kattan düşen halı, mağaza çalışanının başına isabet ettiTRBenzine zam pompaya yansıdı: Bazı illerde litre fiyatı 70 TL'ye yaklaştıTRBrandon Davies 34 Yaşında Basketbolu Bıraktığını AçıkladıTRÖSYM'den Okul Birinciliği Bilgileri İçin Önemli DuyuruTRGalatasaray, Can Uzun transferinde vites yükseltti: Pazarlıklarda ilerleme varTRFethiye'deki Orman Yangını Kontrol Altına Alındı, Evlerin Bahçesine Ulaştığı Anlar KameradaTRRojin Kabaiş'in Telefonu Çin'de de Açılamadı: Tüm Veriler Silinebilir UyarısıTRLavrov, ABD'nin Ukrayna'ya silah sevkiyatını 'kabul edilemez' buldu; AB'den yeni yaptırım paketiTRLGS Türkiye Birincisi Meryem Sakman Tercihini YaptıTRAB, Rusya'ya Yönelik 21. Yaptırım Paketini Onayladı
Newsgather

q1 results

Stable14 articles8 sourcesDernière mise à jour: 09/07/2026

Derniers articles

Merck Q1 Results Beat Estimates on Keytruda Demand, Raises 2026 Guidance
ACTU
30/04/2026Résumé IA

Merck Q1 Results Beat Estimates on Keytruda Demand, Raises 2026 Guidance

Merck reported first-quarter 2026 results exceeding Wall Street expectations with $16.29B revenue, driven by strong Keytruda sales of $8.03B (up 12%). The pharma giant narrowed its 2026 revenue guidance to $65.8B-$67B and raised adjusted earnings outlook to $5.04-$5.16 per share. The company posted a net loss of $4.24B due to a $3.62 per share charge from its Cidara Therapeutics acquisition, part of its strategy to offset upcoming generic competition for Keytruda in 2028 and diabetes drugs Januvia/Janumet later this year.

C
CNBC
2 min de lecture
European Banks and TotalEnergies Post Strong Q1 Results Amid Middle East Uncertainty
Urgent
Business·29/04/2026Résumé IA

European Banks and TotalEnergies Post Strong Q1 Results Amid Middle East Uncertainty

Europe's largest banks and TotalEnergies reported upbeat first-quarter results on Wednesday, with Deutsche Bank posting a record €2.2bn profit, Santander posting €5.5bn attributable profit, and UBS posting an 80% profit jump. TotalEnergies saw net income rise 51% to $5.8bn. Executives flagged rising uncertainty from the Middle East conflict and its ripple effects on energy prices, consumer confidence and European interest rates, with the ECB warning of downward growth revisions.

E
Euronews Business
4 min de lecture
Intel Shares Surge 22% on Strong Q1 Results, AI Demand Revival
En développement
Business·24/04/2026Résumé IA

Intel Shares Surge 22% on Strong Q1 Results, AI Demand Revival

Intel shares surged 22% on Friday, putting the stock on track for its best day since 1973, as investors rewarded signs of renewed growth driven by AI demand. The chipmaker reported Q1 revenue of $13.58 billion, up 7.2% year-over-year, with data center revenue jumping 22% to $5.1 billion. CEO Lip-Bu Tan, who took over early last year, has revived Wall Street interest by securing investments from the Trump administration and Nvidia, and pushing forward with next-generation 14A manufacturing technology.

C
CNBC
Intel shares surge 26.7% in biggest single-day gain since 1987 after strong Q1 results
ACTU
24/04/2026Résumé IA

Intel shares surge 26.7% in biggest single-day gain since 1987 after strong Q1 results

Intel shares jumped 26.7% on Friday in what could be the chipmaker's strongest single-day gain since 1987, after reporting Q1 revenue of $13.58 billion, beating forecasts of $12.3 billion. The rally continued after hours with shares rising another 20%. The US Trump administration acquired a 9.9% stake in Intel in 2025 for $8.9 billion at $20.47 per share; with shares now at $81.3, the investment has gained nearly 300%.

T
Times of India
Texas Instruments Shares Surge 19% After Strong Q1 Results, Upbeat Guidance
En développement
Business·23/04/2026Résumé IA

Texas Instruments Shares Surge 19% After Strong Q1 Results, Upbeat Guidance

Texas Instruments posted its best Wall Street day since 2000 after reporting Q1 revenue of $4.83 billion (up 19%) and EPS of $1.68, both beating estimates. The chipmaker gave upbeat Q2 guidance of $5-$5.4 billion in revenue. Data center segment revenue surged ~90% YoY as hyperscalers like Meta and Amazon build AI infrastructure. Shares closed at a record, up 63% YTD.

C
CNBC
2 min de lecture